Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Biling Weitong Granules plus short-course dual therapy for initial Helicobacter pylori eradication
ChiCTR2600133142Phase 4Not yet recruiting
- Sponsor
- The Affiliated Hospital of Xuzhou Medical University
- Start
- Sep 2026
- Countries
- 1
01
Overview
Phase 4, open-label trial of biling weitong granules in Helicobacter pylori infection (2 arms), sponsored by The Affiliated Hospital of Xuzhou Medical University. Primary endpoint: Helicobacter pylori eradication rate. Planned start Sep 2026; status: not yet recruiting.
02
Drugs
biling weitong granules
03
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on ChiCTR2600133142.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600133142.